Improving Medication Adherence in Chronic Rheumatic Diseases
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 102
- 试验地点
- 1
- 主要终点
- Intervention Feasibility as Measured by Number of Providers Agreeing to Participate
研究概览
简要总结
The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all providers at Southpoint Rheumatology All patients with a rheumatic disease diagnosis currently prescribed at least one rheumatic medication will be included in the analysis
排除标准
- •new patients, those who are not prescribed any rheumatic disease medications, or do not have available pharmacy refill data
研究组 & 干预措施
Intervention
Clinicians in this arm will be trained to conduct the adherence intervention in general rheumatology clinic with all follow up patients with a chronic rheumatic disease.
Patients seen by these clinicians will contribute to the outcome data collection.
干预措施: Clinician-led adherence intervention (Behavioral)
结局指标
主要结局
Intervention Feasibility as Measured by Number of Providers Agreeing to Participate
时间窗: 4 weeks
Intervention Feasibility as Measured by the Feasibility of Intervention Measure (FIM)
时间窗: 4 weeks
Provider survey based on the Feasibility of Intervention Measure, scores range from 1-5, where 5 is most feasible.
Intervention Feasibility as Measured by Percent of Visits With EMR Documentation of Providers Reviewing Refills
时间窗: 4 weeks
Calculated for the full population, not per participant.
次要结局
- Intervention Acceptability as Measured by the Percentage of Patients Who Report a Positive Feeling After Having an Adherence Conversation With Their Providers(4 weeks)
- Fidelity as Measured by the Number of Participants With EMR Documentation of Completing the Intervention Components of Reviewing Pharmacy Refills and Using Effective Communication Strategies(4 weeks)
- Intervention Acceptability as Measured by the Acceptability of Intervention Measure (AIM)(4 weeks)
- Fidelity as Measured by the Number of Participants With Clinicians Conducting the Intervention Components of Reviewing Pharmacy Refills and Using Effective Communication Strategies(4 weeks)
- Change in MPR (Medication Possession Ratio) as a Percentage for the Entire Sample(Baseline to 3 months)